1. European Union (2007) Regulation (EC) No 1394/2007 of the European Parliament and Council of 13 November 2007 on Advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004. Official Journal of the European Union L324:121–137
2. European Union (2001) Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. Official Journal of the European Union L311:67–128
3. European Union (2003) Commission Directive 2003/63/EC of 25 June 2003 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code related to medicinal products for human use. Official Journal of the European Union L159:46–94
4. Bock A-K, Rodriguez-Cerezo E, Hüsing B et al (2005) Human tissue-engineered products: Potential socio-economic impacts of a new European regulatory framework for authorisation, supervision and vigilance. Synthesis report Eur 21838 EN, Institute for Prospective Technology Studies, Seville Spain, pp 1–58
5. Commission of the European Communities (2005) Proposal for a Regulation of the European Parliament and Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004. Impact assessment, COM (2005) 567 final, pp 1–68